OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
221
Results
Show all
Save search
Copy query
Show results for
Unknown
(216)
Metabolomics
(5)
Repository
MetaboLights
(5)
Technology Type
Mass spectrometry
(5)
Instrument Platform
Liquid Chromatography MS - negative - reverse phase
(2)
Liquid Chromatography MS - positive - reverse phase
(2)
Gas Chromatography MS - positive
(1)
Liquid Chromatography MS - Negative (LC-MS (Negative))
(1)
Liquid Chromatography MS - Positive (LC-MS (Positive))
(1)
Liquid Chromatography Tandem MS (LC-MS/MS)
(1)
Q Exactive
(1)
SYNAPT HDMS (Waters)
(1)
Publication Date
2020
(2)
2022
(1)
2021
(1)
2017
(1)
CHEBI ID
CHEBI:133244
(3)
CHEBI:16065
(3)
CHEBI:16243
(3)
CHEBI:16914
(3)
CHEBI:17858
(3)
CHEBI:28794
(3)
CHEBI:31832
(3)
CHEBI:31969
(3)
CHEBI:80463
(3)
CHEBI:10026
(2)
CHEBI:10070
(2)
CHEBI:131659
(2)
CHEBI:131687
(2)
CHEBI:131688
(2)
CHEBI:131689
(2)
CHEBI:131692
(2)
CHEBI:131738
(2)
CHEBI:131924
(2)
CHEBI:133086
(2)
CHEBI:133144
(2)
CHEBI:133365
(2)
CHEBI:133456
(2)
CHEBI:134007
(2)
CHEBI:134761
(2)
CHEBI:136949
(2)
CHEBI:137853
(2)
CHEBI:138195
(2)
CHEBI:138499
(2)
CHEBI:139
(2)
CHEBI:143715
(2)
Metabolite Name
(1->3)-beta-D-Galactopyranans
(2)
(2,6-beta-D-Fructosyl)n
(2)
1,3-beta-D-Oligoglucan
(2)
1,6-beta-D-Glucan
(2)
1-16:0-lysoPE
(2)
1-kestotriose
(2)
10,16-Dihydroxyhexadecanoic acid
(2)
1F-beta-D-Fructosylsucrose
(2)
6-kestotriose
(2)
6F-alpha-D-Galactosylsucrose
(2)
Adenosine
(2)
Azelaic acid
(2)
Bracteatin
(2)
Caffeic aldehyde
(2)
Cellotriose
(2)
Citrate
(2)
Colneleic acid
(2)
D-Gal alpha 1->6D-Gal alpha 1->6D-Glucose
(2)
Decenedioic acid
(2)
Dihydrocoumarin
(2)
Dihydrophaseic acid
(2)
Fumarate
(2)
Galactitol
(2)
Galactomannan
(2)
Glucose
(2)
Glutathione
(2)
Glycerophosphoglycerol
(2)
Isocitrate
(2)
Isomaltotriose
(2)
Laminarin
(2)
Release Date
2025
(47)
2022
(34)
2021
(34)
2023
(33)
2024
(28)
2020
(10)
2019
(10)
2018
(9)
2026
(5)
2017
(2)
2016
(2)
2015
(1)
2014
(1)
Previous
page
1 / 23
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
23
Next
page
Sort
by:
Relevance
Page size
10
Outcomes of 1.3 million patients undergoing percutaneous coronary intervention according to the presence of cancer and atrial fibrillation: a retrospective study.
Not available
S-EPMC11568383
|
biostudies-literature
Cite
Time-varying comparative effectiveness of surgical or percutaneous revascularization on patient-centred outcomes.
Not available
S-EPMC12685096
|
biostudies-literature
Cite
Twitter-based learning for continuing medical education?
Not available
S-EPMC7197537
|
biostudies-literature
Cite
Prognosis of Acute Ischaemic Stroke Patients with Cancer: A National Inpatient Sample Study.
Not available
S-EPMC8125286
|
biostudies-literature
Cite
Association of Cardiovascular Health Metrics and Mortality Among Individuals With and Without Cancer.
Not available
S-EPMC10944047
|
biostudies-literature
Cite
Prognostic role of CA-125 in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
Not available
S-EPMC10577531
|
biostudies-literature
Cite
Prevalence of Cardiovascular Risk Factors in Osteoarthritis Patients Derived from Primary Care Records: A Systematic Review of Observational Studies.
Not available
S-EPMC7612956
|
biostudies-literature
Cite
Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
Not available
S-EPMC9826290
|
biostudies-literature
Cite
Sex differences in Life's Essential Eight and its Association with mortality among US adults without known cardiovascular disease.
Not available
S-EPMC11208949
|
biostudies-literature
Cite
Metabolic risk factors and the incidence and progression of radiographic hand osteoarthritis: a population-based cohort study.
Not available
S-EPMC6319183
|
biostudies-literature
Cite
Previous
page
1 / 23
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
23
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
